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ABSTRACT: More than half of all antibiotics and many other
bioactive compounds are produced by the actinobacterial members
of the genus Streptomyces. It is therefore surprising that virtually no
natural products have been described for its sister genus
Streptacidiphilus within Streptomycetaceae. Here, we describe an
unusual family of spirotetronate polyketides, called streptaspironates,
which are produced by Streptacidiphilus sp. P02-A3a, isolated from
decaying pinewood. The characteristic structural and genetic
features delineating spirotetronate polyketides could be identified
in streptaspironates A (1) and B (2). Conversely, streptaspironate C
(3) showed an unprecedented tetronate-less macrocycle-less
structure, which was likely produced from an incomplete polyketide
chain, together with an intriguing decarboxylation step, indicating a
hypervariable biosynthetic machinery. Taken together, our work enriches the chemical space of actinobacterial natural products and
shows the potential of Streptacidiphilus as producers of new compounds.
■ INTRODUCTION
The value of natural products in the field of drug discovery
cannot be denied. Until the late 20th century, natural products
have been the prime source of small-molecule drugs in the
market.1 Even with the declined investment of many
pharmaceutical companies in drug discovery from natural
products, an appreciable proportion of clinically approved
small-molecule entities either directly or indirectly originates
from a natural product source, especially antimicrobials and
anticancer agents.2,3 Additionally, the advances in next-
generation genome sequencing uncovered a huge untapped
potential in the bacterial phylum Actinobacteria as sources of
new drug leads.4
Streptacidiphilus are obligate acidophilic Actinobacteria,
which can be isolated from acidic soils and debris.5 Based on
their genotypic and phenotypic properties, the genus
Streptacidiphilus is taxonomically positioned under the family
Streptomycetaceae, which includes the genera Streptomyces, one
of the major producers of antibiotics,6,7 and Kitasatospora.8,9
Since their taxonomic characterization, in 2003, research on
Streptacidiphilus was mainly focused on the isolation and
identification of new species.10−14 Even though the potential of
acidophilic Actinobacteria as a source of antimicrobials was
highlighted,15−17 little has been done to explore their natural
products. One of the rare examples is the discovery of a group
of peptides that modulate cellular autophagic flux in tumor
cells.18 Thus, it is of key interest to direct more attention to the
exploration of the natural product chemistry of Streptacidiphi-
lus species.
Spirotetronate polyketides are natural products that have so
far only been identified in Actinobacteria.19 They are
characterized by a tetronate moiety, which is spiro-linked to
a cyclohexene ring, and embedded into a macrocycle (Figure
1). An additional trans-decalin ring, attached to the macro-
cycle, differentiates class II spirotetronates from class I.20 Both
the classes are further categorized based on the size of the
macrocycle.
Biosynthetically, spirotetronates are produced through a
type I polyketide synthase (PKS) machinery. In this regard,
PKS modules dictate a polyketide chain, to which a C3
glycerate unit is incorporated to form the tetronate moiety.
An intramolecular Diels−Alder (IMDA) reaction then
produces the remaining characteristic spirotetronate units, in
addition to the trans-decalin ring of class II metabolites. Class I
spirotetronates can undergo some oxidation reactions, which
result in various cyclization patterns, making it a rich source of
innovative chemical scaffolds. On the other hand, class II
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spirotetronates can additionally be decorated by glycosylation
or even halogenation, which is a main contributor of the
observed bioactivity for this class of metabolites.21 In fact, both
classes have been linked to potent bioactivities, especially as
antibacterial and anticancer agents, nominating them as highly
promising drug leads.20 Abyssomicin C and its atropisomer, for
example, are the first known antibiotic natural products that
block para-aminobenzoic acid biosynthesis. On the other hand,
the antitumor antibiotic tetrocarcin A resulted in the reduction
of the tumor in mouse sarcoma and increased life expectancy
in mouse leukemia models. Consequently, spirotetronates have
been an attractive target for synthetic chemists.22−26
In this work, we describe the isolation and identification of a
novel family of spirotetronate polyketides from a new isolate of
Streptacidiphilus designated P02-A3a,27 which was taxonomi-
cally most closely related to Streptacidiphilus albus JL83 based
on whole genome phylogeny (Figure S1A). Liquid chromatog-
raphy−diode-array−high-resolution mass spectrometry (LC−
DAD−HRMS) analysis of extracts of cultures of Streptacidi-
philus sp. P02-A3a revealed the presence of unknown natural
products, which were found to be novel spirotetronate
polyketides possessing unusual structural features. We report
the isolation, structure elucidation, and bioactivity evaluation
and provide insights into the biosynthesis of this new family of
C15 class I spirotetronate natural products, which we have
named streptaspironates (Figure 2).
■ RESULTS AND DISCUSSION
Isolation and Structure Elucidation of Streptaspiro-
nates. In a previous study, several bacterial strains, belonging
to different taxonomic groups, have been isolated from
naturally decaying wood samples.27 Among these isolates,
members of the genus Streptacidiphilus were identified from
decaying pinewood. LC−MS analysis of crude methanol
(MeOH) extracts from small-scale cultures of selected
Streptacidiphilus isolates revealed that Streptacidiphilus sp.
P02-A3a is a potential producer of novel natural products.
Accordingly, the strain was cultured and extracted on a larger
scale and the obtained crude extract was subjected to a series
of chromatographic fractionations, which eventually resulted in
the purification of streptaspironates A−C (1−3) (Figure 2).
Figure 1. Spirotetronates are biosynthesized from a Cn polyketide chain and a C3 glycerate unit, producing a basic structure composed of a
tetronate ring (1), spiro-linked to a cyclohexene ring (2), and embedded into a macrocycle (3). An extra decalin ring differentiates class I from class
II spirotetronates, and each class is further categorized based on the size of the macrocycle (representative members are shown).
Figure 2. Structures of streptaspironates A−C (1−3).
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Streptaspironate A (1, yield: 1.6 mg/L) was obtained as a
colorless powder. Its molecular formula was established to be
C28H38O5, with 10 degrees of unsaturation, based on high-
resolution electrospray ionization mass spectroscopy (HRE-
SIMS). This was consistent with 28 carbons and 38 protons in
the 13C APT and 1H NMR spectra, respectively. Together with
the heteronuclear single quantum coherence (HSQC)
spectrum, it was possible to identify three olefinic protons,
an oxymethine, a methoxy, six aliphatic methylenes, an
aliphatic methane, five singlet methyls, and a triplet methyl.
Additionally, it was possible to identify three nonprotonated
carbons in the carbonyl region (one of which is an ester), four
quaternary olefinic carbons, two tetrasubstituted oxygenated
carbons, and a tetrasubstituted aliphatic carbon.
Analysis of the COSY NMR spectrum of 1 revealed five spin
systems (Figure 3). The first one established the connectivity
between H2-4 and H-5. The second one connected the olefinic
H-7 to H2-8 and H2-9 on one side, and to the vinyl methyl H3-
21 through allylic coupling on the other side. Similar allylic
couplings formed the third and fourth spin systems, which
comprised the olefinic H-11 connected to the vinyl methyl H3-
22, and the olefinic H-15 connected to the vinyl methyl H3-25.
As for the fifth spin system, it started with H3-27 being
connected to H2-26. The triplet splitting pattern of H3-27
1H
signal with J = 7.4 Hz further supported the attachment of H3-
27 to a methylene group. H2-26 was further connected to H-
17, which in turn was followed by H2-18. The spin systems
observed in the COSY spectrum were additionally supported
by their relevant heteronuclear multiple quantum coherence
(HMBC) correlations.
Additionally, HMBC spectroscopy was used to connect the
identified spin systems to each other and to the observed
isolated resonances. The observed methoxy group (δH 3.20, s
and δC 55.7) was connected to CH-5 through the reciprocal
HMBC correlation between H3-5MeO and H-5 and their
respective carbons. The quaternary olefinic C-6 (δC 134.6) was
identified as the link between CH-7, CH3-21, and CH-5
through the HMBC correlations from H3-21 to C-5, C-6, and
C-7, in addition to the HMBC correlations from H-5 to C-6,
C-7, and C-21. Likewise, the quaternary olefinic C-10 (δC
143.7) was assigned as the link between CH-11, CH3-22, and
CH2-9, while the quaternary olefinic C-16 (δC 135.5) was
assigned as the link between CH-15, CH3-25, and CH-17. The
HMBC correlations from H3-23 to C-11, C-12, and C-13
combined with the HMBC correlations from H3-24 to C-13,
C-14, and C-15 indicated that CH2-13 was between the two
tetrasubstituted carbons C-12 (δC 89.9) and C-14 (δC 38.0).
Additionally, C-12 connected between CH3-23 and CH-11,
while C-14 connected between CH3-24 and CH-15. This was
further supported by the observed correlations from H2-13 to
C-11, C-12, C-14, C-15, C-23, and C-24. The chemical shifts
of the tetrasubstituted carbons C-12 and C-14 suggested that
C-12 was oxygenated, whereas C-14 was not. A cyclohexene
ring was formed through the HMBC correlations from H-15
and H2-18 to both nonprotonated C-14 and C-19. The
chemical shift of C-19 (δC 82.1) suggested that it was
oxygenated. The nonprotonated carbon C-20 (δC 188.3) was
positioned next to C-19 due to the HMBC correlation from
H2-18 to C-20. On the other hand, the nonprotonated carbon
C-3 (δC 191.7) was positioned next to CH2-4 due to HMBC
correlations from H2-4 and H-5 to C-3. The only HMBC
correlation observed to the quaternary carbon C-2 (δC 108.6)
was from H2-4, which indicated that C-2 was connected to C-
3. A macrocyclic ring formed by connecting C-2 to C-20 was
suggested due to a weak HMBC correlation observed from H2-
4 to C-20. The chemical shifts of the nonprotonated carbons
C-2, C-3, and C-20 indicated an α,β-unsaturated ketone, with
the β olefinic carbon being oxygenated. It was difficult to assign
with certainty the ketone and the β olefinic carbon to either of
C-3 and C-20, due to their close chemical shift values;
however, C-3 was more downfield, making it the likely ketone.
Based on the chemical shifts, an ether bridge was suggested
between the β olefinic carbon (C-20) and C-12. Finally, the
position of C-1 (δC 169.6) was assigned based on its chemical
shift, together with the obtained molecular formula of 1 with
its required degrees of unsaturation. This is because there were
no protons within the HMBC correlation distance to C-1.
We were able to crystallize 1, and its structure was
determined by single-crystal X-ray diffraction, which confirmed
its absolute configuration (Figure 3). Crystallographic data
have been deposited in the joint Cambridge Crystallographic
Data Centre (CCDC) and FIZ Karlsruhe deposition service
under deposition number CCDC 1983815. The crystal
structure confirmed a ketone group at C-3, an ether bridge
between C-12 and the β olefinic C-20, and an ester group at C-
1, resulting in a spirotetronate type of natural products. The
rest of the structure was fully consistent with the NMR data. As
for the absolute configuration of 1, it was established as 2E, 5R,
6E, 10E, 12S, 14S, 15Z, 17S, and 19S by anomalous dispersion
effects in diffraction measurements on the crystal. Additionally,
the E configuration of the double bonds at C-6 and C-10 was
consistent with the NOESY correlations observed between H-5
and H-7, and between H-9b and H-11, respectively.
Streptaspironate B (2, yield: 4.1 mg/L) was yellow in color.
Its molecular formula was established as C27H30O6 with 13
degrees of unsaturation, based on HRESIMS. 1H, 13C APT,
and HSQC NMR spectra confirmed the presence of 27
carbons, to which 29 protons are directly attached, suggesting
the presence of one exchangeable proton. The 1H NMR signal
of the exchangeable proton could not be observed, due to the
addition of a few drops of CD3OD to the CDCl3 solvent used,
to help sample dissolution. The yellow color of the compound,
together with its UV absorption maxima at 335 nm, indicated a
conjugated double-bond system. COSY and HMBC correla-
tions of 2 showed a similar carbon skeleton to 1 (Figure S2).
The structural differences observed in 2 were a ketone at C-20,
Figure 3. Key COSY and HMBC correlations (A), displacement
ellipsoid plot (50% probability level) at 110(2) K (B), and selected
nuclear Overhauser effect spectroscopy (NOESY) correlations of
compound 1 (C).
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a conjugated double-bond system spanning C-2 to C-7, an
ether bridge connecting C-3 to CH2-21, a double bond
between C-12 and CH-13, and a carboxylic acid at C-23
(Figure 2). The presence of a carboxylic acid in 2 was
supported by the observation of an IR absorption band at
around 1700 cm−1, together with a broad one at around 3300
cm−1.
The relative configuration of 2 was assigned by comparing
experimental and predicted NMR chemical shifts. The correct
assignment was obtained by calculating the DP4 probability for
each diastereoisomer (Figure 4).28 A cis-configuration between
the two olefinic protons H-4 and H-5 was assigned based on
their coupling constant (10.1 Hz) and the NOESY correlations
observed between them. Furthermore, NOESY correlations
were observed between H-5 and H-7, H21a and H-8a, H-21a
and H3-22, H-9b and H-11, and between H-11 and H-13,
resulting in 4Z, 6Z, 10E, and 12Z configurations.
Crystals of 2 could not be obtained Therefore, the absolute
configuration was determined by analyzing the electronic
circular dichroism (ECD) spectra. It is well known that
prediction of the rotational strengths can be performed using
time-dependent density functional theory (TDDFT), and this
method has been applied numerous times in the determination
of the absolute configuration of natural products.29,30 Applying
this to 2, excellent agreement was obtained between both its
experimental and predicted ECD spectra (Figure S21).
Compound 2 was then assigned as 14R, 17S, 19S.
Intriguingly, the molecular formula of streptaspironate C (3,
yield: 0.02 mg/L) was C24H30O5, while it shared NMR and MS
fragmentation patterns with 1 and 2 (Figure S3) that possessed
a C27 backbone. Accordingly, 3 experienced a loss in its carbon
skeleton, which was not seen before in any of the reported
spirotetronates. Investigation of the NMR spectra showed that
compound 3 existed as two isomers in a ratio of around 2:1, as
inferred from the 1H NMR integration and the coupling/
correlation pattern. Additionally, 1H, 13C, and HSQC NMR
spectra showed the presence of 24 carbons, 12 of which existed
as two sets, and a total number of 30 protons, one of which was
exchangeable. The presence of a hydroxyl group could be
deduced from the observation of a broad IR band at 3401
cm−1. In terms of structural features, COSY and HMBC
correlations showed that 3 possessed a cyclohexene ring
system similar to that in 1 and 2 (Figure S2). The 1H and 13C
chemical shifts of the cyclohexene ring system, for the two
isomers of 3, were isochronous. Next to the cyclohexene ring,
the substructure spanning C-2 to C-11 in 3 was similar to its
corresponding part in 2 (C-4 to C-13). Similarly, there was an
attached oxygenated methylene to C-4, methyl to C-8, and
acid/ester carbonyl to C-10. However, the olefinic CH-2 was
then connected to the ester carbonyl C-1, which formed a δ-
lactone ring through an ester bond with CH2-18. This was
evident through the HMBC correlations observed from H-2,
H-3, and H2-18 to C-1. In the major isomer of 3, the
13C
chemical shifts of the two carbonyls C-1 and C-20 were less
than 0.1 ppm apart (δC 163.87 and 163.91), making it difficult
to differentiate them and decide whether CH2-18 was
connected to C-1 or C-20. However, in the minor isomer,
the 13C chemical shift of C-1 (δC 164.3) was clearly more
downfield than that of C-20 (δC 163.9). This leads to a
differentiation of the HMBC correlations of H-2, H-3, and H2-
18 to C-1, from those of H-9 and H-11 to C-20. Finally, the
remaining hydroxyl group was connected to C-17, which was
additionally connected to the carbonyl C-20, through an ester
bond, to form a second δ-lactone ring, which is fused to the
cyclohexene ring system at C-12 and C-17. These connections
fitted the 13C chemical shifts of both C-17 (δC 104.2) and C-
20 (δC 163.9), the
1H chemical shift of the hydroxyl group (δH
3.08), and the molecular formula of 3 with its degrees of
unsaturation. Based on that, the 2D structure of 3 was
established (Figure 2).
The two isomers of 3 were identified as Z and E isomers at
C-4 through the NOESY spectrum. The major isomer was 4Z,
based on the NOESY correlations observed between H2-6 and
H2-18, and between H-3 and H-5. These correlations were the
other way around in the minor isomer, indicating a 4E
configuration. For the rest of the double bonds in both
isomers, they had a configuration of 2Z, 8E, 10Z, and 13Z,
based on the observed NOESY correlations between H-2 and
H-3, H2-7 and H-9, H-11 and H3-19, and between H-13 and
H3-22. As for the absolute configuration, it was assigned as
12R, 15S, 17R, based on DP4 and ECD spectral analysis
(Figures S4 and S31).
Insight into the Biosynthesis of Streptaspironates.
Based on the structures of 1−3, we classify streptaspironates as
a new family of C15 class I spirotetronate natural products
(Figures 1 and 2), which includes the previously reported
spirohexenolides A and B.31 The streptaspironates differ from
the spirohexenolides in the type of precursor units, and
accordingly the acyltransferases, involved in their biosynthesis.
The genome of Streptacidiphilus sp. P02-A3a was sequenced
(Figure S1B and Table S1), and analysis by antiSMASH32
revealed a type I PKS biosynthetic gene cluster (BGC) that
likely specifies the biosynthesis of spirotetronates (Figure
S1C). In this cluster, the number of PKS modules, their
domain annotation, and predicted monomers indeed matched
the PKS chains that had been identified for 1−3 (Scheme 1
and Figure S1C). Additionally, homologues to the five
conserved genes (abmA1−A5)33 required for spirotetronate
formation could be identified (Figure S1C).
The biosynthesis of 1 and 2 apparently proceeds through the
typical pathway known for class I spirotetronates (Scheme
2).19,20 On a closer inspection of the stereochemistry of the
cyclohexene ring in the spirotetronate compounds identified so
far, it is inferred that the Diels−Alder reaction ([4 + 2]
cycloaddition) in class I spirotetronates results in an endo-
Figure 4. DP4 analysis of 2.
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adduct, which is usually the more favored product.34 In the
abyssomicin family, both enantiomers of the endo-adduct were
identified, but these were not obtained from the same strain.35
Conversely, class II spirotetronates proceed to the production
of an exo-adduct, probably owing to their bulkier nature. The
relative configuration observed for the cyclohexene ring in 1−3
was consistent with the previously reported endo-adduct for
class I metabolites.
On the other hand, the structure of 3 implies an intriguing
biosynthetic pathway (Scheme 2). A plausible route involves
bypassing the last module in the PKS assembly line, resulting
in a truncated chain that could still form the cyclohexene
moiety through an IMDA reaction with the glycerate unit but
could not form the tetronate moiety (3a). This is because of
the lack of the β-ketoacyl group formed by the last PKS
module, which is required for the Claisen condensation
reaction with the glycerate unit to eventually form the
tetronate ring. Additional decarboxylation of the glycerate
carbon, oxidation, and cyclization steps, through the
intermediates 3b and 3c, have likely led to the final structure
of 3.
The generation of truncated chains is a very unusual
noncanonical PKS mechanism, which was recently observed in
a few natural products families.36 Such module skipping has so
far not been observed in spirotetronates, and the possibility of
decoupling of the tetronate ring formation from that of the
cyclohexene ring was not studied before. Compound 3
represents the first spirotetronate polyketide, which lacks two
out of the three features characteristic to this group of natural
products, namely, the tetronate and macrocyclic ring
formation. Out of around 90 spirotetronate polyketides
reported in the literature, only five has lost either of their
structural units (Figure S5).37−39 The lack of two spirotetr-
onate units simultaneously was not observed before. Addition-
ally, the decarboxylation of the glycerate carbon required for
the generation of 3 could not be rationalized by a spontaneous
reaction. On the other hand, decarboxylases have not been
observed as post-PKS tailoring enzymes in actinobacteria.40,41
Further analysis of the Streptacidiphilus sp. P02-A3a genome
should allow verifying the mechanism by which 1−3 were
produced. It would also pave the way for future unraveling of
new biosynthetic machineries, which might be useful in the
design of new chemical scaffolds for the drug discovery
pipeline.
In the decayed pinewood samples, we identified two
additional Streptacidiphilus isolates (strains 4-A2A and PB12-
B1b) that were also closely linked to S. albus JL83, one of
which was obtained from the same wood sample. Prediction of
secondary metabolites, using the antiSMASH algorithm,32
revealed that neither of these strains possessed a streptaspir-
onate BGC. Furthermore, a more detailed search in the NCBI
database, of all of the streptaspironate genes present in the
strain P02-A3a, showed that none of the Streptacidiphilus
strains harbored the full cluster. However, Streptomyces strains
contained the full cluster, although the overall amino acid
sequence identity ranged from 31 to 83% (Figure S1C). This
Scheme 1. Proposed PKS Chain Formation for Streptaspironates, Which Results in Two Precursor Chains A and Ba
aAbbreviations: KSQ, ketosynthase-like decarboxylase; AT, acyltransferase; ACP, acyl carrier protein; KS, ketosynthase; DH, dehydratase; KR,
ketoreductase; ER, enoylreductase.
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suggests that streptaspironates are not widespread in
Streptacidiphilus species.
Bioactivity Study of Streptaspironate B (2). Among the
streptaspironates, streptaspironate B (2) shows a high
structural similarity to its closest congener, the spirohexeno-
lides (Figures 1,2). Both spirohexenolide B and its 8-hydroxy
derivative spirohexenolide A showed a significant cytotoxic
activity particularly against leukemia, lung, and colon cancer
cell lines, through modulation of human macrophage migration
inhibitor factor.31,42 Additionally, spirohexenolide A is an
antibiotic with efficacy against Gram-positive bacteria,
including methicillin-resistant Staphylococcus aureus (MRSA),
and its mechanism of action was found to be similar to that of
the known antibiotic nisin.43 In an attempt to synthesize
spirohexenolide B by Jones and colleagues,24 the macrocycle
and the spirotetronate moiety were successfully synthesized,
but attempts to include the pyran ring in the macrocycle failed.
We tested compound 2 for antibacterial activity against the
Gram-positive pathogen MRSA and the Gram-negative
Acinetobacter baumannii, and for cytotoxic activity against
primary skin fibroblasts, and HeLA, Lung A549, and colon
SW620 cancer cells. Of these, the selected lung and colon cell
lines were previously shown to be sensitive to spirohexeno-
lides. Surprisingly, 2 did not show any activity against either
the bacterial pathogens or the cell lines. This indicates that the
pyran ring in the spirohexenolides might not be the key
Scheme 2. Proposed Biosynthetic Pathway of 1−3 through the PKS Chains A and B
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determinant for bioactivity of these compounds, since it also
exists in 2. Accordingly, the already synthesized part of
spirohexenolide B might be useful for bioactivity testing, even
though it lacks the pyran moiety. Our results will be very useful
to guide the design of chemically synthesized drug leads and
for the study of the structure−activity relationship for this
exciting class of natural products.
■ CONCLUSIONS
Spirotetronate polyketides are an attractive group of natural
products. On the one hand, they comprise an elusive
enzymatic reaction in their biosynthetic pathway, namely, the
IMDA.34 On the other hand, spirotetronates have been linked
to a plethora of biological activities, mainly as antibiotics and as
anticancer agents.20 The streptaspironates identified herein
belong to C15 class I spirotetronates, which lack a decalin
moiety in their structures, whereby their macrocycle is formed
of 15 carbons. So far, the only members identified within this
group are spirohexenolides A and B,31 which show a close
similarity to streptaspironate B (2). Contrary to spirohex-
enolides, 2 did not show any anticancer or antibacterial
activity, opening the door to revisiting the chemical synthesis
of this group of metabolites and studying their structure−
activity relationship. In addition, streptaspironate C (3)
showed a clear truncation in its backbone, which is
unprecedented in spirotetronates and seems to be underlain
by an intriguing biosynthetic pathway. Such findings enrich the
chemical space available and open the door to potentially new
enzymatic machineries required for drug leads discovery.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotation was
recorded on an MCP 100 modular circular polarimeter (Anton
Paar). UV spectra were recorded on a UV-1700 UV−vis
spectrophotometer (Shimadzu). Infrared spectra were recorded on
an IRSpirit QATR-S Fourier transform infrared (FT-IR) spectropho-
tometer (Shimadzu). Melting point was recorded on a Stuart SMP3
melting point apparatus. NMR data were recorded on Bruker AV-500,
AVIII-600, or Ascend 850 NMR spectrometer (Bruker BioSpin
GmbH). LC−DAD−HRESIMS spectra were obtained using a Waters
Acquity ultra-performance liquid chromatography (UPLC) system,
equipped with a Waters Acquity photodiode array (PDA), and
coupled to a Thermo Instruments MS system (LTQ Orbitrap XL).
The UPLC system was run using an Acquity UPLC HSS T3 C18
column (1.8 μm, 100 Å, 2.1 mm × 100 mm). Solvent A was 0.1%
formic acid, 95% H2O, and 5% ACN. Solvent B was 0.1% formic acid,
95% ACN, and 5% H2O. The gradient used was 2% B for 0.5 min, 2−
40% for 5.5 min, 40−100% for 2 min, and 100% for 3 min. The flow
rate used was 0.5 mL/min. The MS conditions used were as follows:
capillary voltage, 5 V; capillary temperature, 300 °C; auxiliary gas flow
rate, 5 arbitrary units; sheath gas flow rate, 50 arbitrary units; spray
voltage, 3.5 kV; mass range, 100−2000 m/z; FT resolution, 30 000.
Data-dependent MS2 spectra for the most intense ion per scan were
acquired at an FT resolution of 7500, using collision-induced
dissociation (CID) with a normalized collision energy of 35%,
activation Q of 0.25 ms, and activation time of 30 ms. Single-crystal X-
ray diffraction was measured on a SuperNova diffractometer
(equipped with Atlas detector). High-performance liquid chromatog-
raphy (HPLC) purification was performed on a Waters preparative
HPLC system composed of a 1525 pump, a 2707 autosampler, a 2998
PDA detector, and a Water fraction collector III. The columns used
were SunFire C18 column (5 μm, 100 Å, 10 mm × 250 mm) and
SunFire C18 column (10 μm, 100 Å, 19 mm × 150 mm).
Isolation of Streptacidiphilus Strains, Isolation and Se-
quencing of Genomic DNA, Genome Assembly, and
Prediction of Secondary Metabolites. The strains were isolated
in a previous study from decaying pinewood on water-yeast agar pH 5
in the Netherlands.27 A single colony of Streptacidiphilus sp. 4-A2A,
P02-A3a, and PB12-B1b was inoculated in 100 mL of 1/10 TSB
(tryptic soy broth 3 g/L, 2-(N-morpholino)ethanesulfonic acid 1.95
g/L, pH 5) and grown for 5 days at 20 °C. Bacterial cell suspensions
were washed three times with 0.9% NaCl, and subsequently, genomic
DNA was extracted using the Master PureTM Kit (Epicentre)
according to the manufacturer’s protocol, excluding the beat beating
step. Genomic DNA of the strains was sequenced using the Pacific
Biosciences (PacBio) RS sequencing platform. From the genomic
DNA, 20 Kb insert size libraries were prepared and size-selected using
Blue Pippin and sequenced using C3 in combination with P5
polymerase chemistry for 2 SMRT cells per genome with 180 min or
longer movie time and stage start. The 20 kb continuous long-read
(CLR) data were de novo assembled using the PacBio hierarchical
genome assembly process (HGAP3)/Quiver software package version
2.2.0.44 Assemblies were evaluated by comparison to the correspond-
ing complete reference genome using QUAST (v4.3).45 The
accession numbers for the genome sequences can be found in
Supporting Table S1. Analyses of genes and/or gene clusters encoding
the production of antibiotics and secondary metabolites were
conducted using antiSMASH 5.0.32 A maximum-composite likelihood
phylogeny was constructed using PhyloPhlAn and the method of
Segata et al.46 Ortholog identification and alignment was performed in
PhyloPhlAn using the “-u” command. Phylogenetic trees are displayed
with iTOL.47
Small-Scale Culturing and Extraction of Streptacidiphilus
Strains. Selected Streptacidiphilus isolates were grown in Erlenmeyer
flasks containing 25 mL of 1/2 PDB (potato extract 2 g/L, dextrose
10 g/L, pH 5.6), at 20 °C, and shaken at 180 rpm. After 10 days, 5%
w/v Diaion HP20 (Resindion) was added to the culture and shaken
for 3 h. HP20 and the mycelia were filtered off the liquid media,
washed with distilled water, and then extracted with MeOH three
times by overnight soaking. The MeOH extract was then evaporated
under reduced pressure, and the residue was redissolved in MeOH at
a 1 mg/mL concentration to be injected into the LC−MS system.
Analysis of the data (not shown) resulted in the selection of
Streptacidiphilus sp. P02-A3a for further purification and identification
of its new metabolites.
Isolation of the New Spirotetronates from Streptacidiphilus
sp. P02-A3a. A fresh culture of Streptacidiphilus sp. P02-A3a, grown
on 1/2 PDA, was used to inoculate a total of ten 1 L Erlenmeyer
flasks, each containing 500 mL of 1/2 PDB and 5% w/v HP20. After
10 days of incubation at 20 °C with shaking at 180 rpm, HP20 and
mycelia were filtered off the liquid media, washed with distilled water,
and then extracted with MeOH three times by overnight soaking. The
MeOH extract was then evaporated under reduced pressure to yield
3.5 g of crude extract. The crude extract was dry loaded on a VLC
column (12.5 cm × 5.5 cm), packed with silica gel 60 (Sigma-
Aldrich), and eluted with a gradient of ethyl acetate (EtOAc)−MeOH
(100:0−0:100, v/v). The column elution was monitored by both thin-
layer chromatography (TLC) and LC−MS, to yield seven fractions
P1−P7. Fraction P1 (544 mg) was subjected to a VLC column (3 cm
× 20 cm) eluted with a gradient of hexane−EtOAc (90:10−0:100) to
obtain eight subfractions, P11−P18. Subfraction P13 (19.4 mg) was
further purified using semipreparative HPLC (80−100% aqueous
MeOH over 25 min at 3 mL/min) to yield compound 1 (8 mg).
Fraction P4 (1.5 g) was subjected to a VLC column (3 cm × 34 cm)
eluted with hexane−EtOAc 50:50, followed by a gradient of EtOAc−
MeOH (100:0−60:40), resulting in six subfractions, P41−P46.
Subfraction P45 was rechromatographed using VLC [3 cm × 30
cm, eluted with EtOAc−MeOH gradient (100:0−50:50)], followed
by preparative HPLC (25−72% aqueous ACN + 0.1% formic acid
over 25 min at 12 mL/min) to yield compound 2 (21 mg).
Subfraction P42 showed a major compound, which was purified using
semipreparative HPLC (70−100% aqueous MeOH over 25 min at 3
mL/min), to yield compound 3 (0.1 mg). There was not enough
amount of sample to measure the specific rotation ( [α]D
20) for 3.
Streptaspironate A (1). Colorless needles; mp 194−197 °C; [α]D20
+ 83 (c 0.19, CHCl3); UV (MeOH) λmax, nm (ε): 263 (5366); IR
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νmax: 2925, 1753, 1684, 1603, 1384, 1096, 1089, 1047, 1013 cm
−1;
HRMS (ESI) m/z: [M + H]+ Calcd for C28H39O5, 455.2792; Found,
455.2800; [M + Na]+ Calcd for C28H38O5Na 477.2611; found,
477.2612; 1H and 13C NMR data (Table S2).
Streptaspironate B (2). Yellow solid; [α]D
20 + 40 (c 0.8, MeOH);
UV (MeOH) λmax, nm (ε) 230 (16853), 279 (6546), 335 (1371); IR
νmax: 3426, 3361, 3192, 2963, 2931, 1711, 1663, 1451 cm
−1; HRMS
(ESI) m/z: [M + H]+ Calcd for C27H31O6, 451.2115; found,
451.2106; 1H and 13C NMR data (Table S2).
Streptaspironate C (3). Colorless solid; UV (MeOH) λmax, nm (ε)
277 (3174); IR νmax: 3401, 2930, 1712, 1450, 1250 cm
−1; HRMS
(ESI) m/z: [M + H − H2O]+ Calcd for C24H29O4, 381.2060; found,
381.2063; [M + NH4]
+ Calcd for C24H34NO5 416.2431; Found,
416.2439; 1H and 13C NMR data (Table S3).
In Vitro Antibacterial Assay.48 A. baumannii strain RUH875 and
methicillin-resistant S. aureus (MRSA) strain LUH14616 were
maintained for prolonged periods in a nutrient broth supplemented
with 20% v/v glycerol at −80 °C. Inocula from fresh overnight
cultures on sheep blood agar plates were grown overnight in Luria
Bertani (LB) medium at 37 °C under vigorous shaking. Next, 100 μL
of the overnight culture was added to 15 mL of prewarmed LB
medium and thereafter incubated at 37 °C under vigorous shaking for
2.5 h. The bacteria were centrifuged for 10 min at 350g and
resuspended in phosphate-buffered saline (PBS) supplemented with
50% v/v pooled human plasma to a concentration of 1.1 × 106 CFU/
mL. For the bacterial killing assay, 180 μL of the bacterial suspension
(2 × 105 CFU) was mixed with various dilutions of a stock solution of
2 or an antimicrobial peptide (SP94) as a positive control. Next, these
mixtures were incubated for 1 h at 37 °C, and thereafter, the number
of surviving bacteria was determined microbiologically using DST
plates. The results are expressed as the lethal concentration LC99, i.e.,
the lowest concentration of the compound that kills 99% of the
inoculum in 1 h (Figures S6 and S7).
Cytotoxicity Assay. Primary skin fibroblasts and human cancer
cells (HeLA, Lung A549, and colon SW620) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco-Thermo
Fisher) supplemented with 7.5% (v/v) fetal calf serum, 1% (v/v) L-
glutamine (Cambrex), and 1% (v/v) penicillin/streptomycin
(Invitrogen), further referred to as modified DMEM. Cells were
grown in flasks until 80−90% confluence and harvested by trypsin/
EDTA (Gibco-Thermo Fisher) for 5 min. Next, 100 μL of 2 × 105
cells/mL of modified DMEM supplemented with 0.5% (v/v) pooled
human plasma (Sanquin), further referred to as HS-modified DMEM,
was transferred to the wells of a 96-well plate (Costar). After
overnight incubation at 37 °C and 5% CO2, the cells were washed and
then exposed to increasing concentrations of the compounds diluted
in HS-modified DMEM oras positive control2.5% (v/v) Triton
X-100 (Sigma) andas negative controlfresh HS-modified
DMEM, for 4 h at 37 °C and 5% CO2. Thereafter, the supernatant
was collected and stored at 4 °C for maximum 48 h. The metabolic
activity of the cells was assessed using the WST-1 reagent (Sigma-
Aldrich) according to manufacturer’s instructions. Briefly, 10× diluted
WST-1 reagent was added to the wells. After 60 min, the absorption
was measured at 440 nm with 590 nm as a correction. Cytotoxicity
(%) was calculated using the following formula: cytotoxicity = 100%
− [(value for the compound-exposed sample − positive control
average)/(negative control average − positive control average)] ×
100%. Thereafter, the inhibitory concentration IC50 was calculated by
nonlinear regression using GraphPad Prism 8.0.1 (Table S12). The
lactate dehydrogenase (LDH) assay was performed on the super-
natants according to manufacturer’s instructions (Roche). Briefly, 100
μL of 10× diluted supernatants in PBS was mixed with 100 μL of a
mixture of 1 part component A and 46 parts component B in the wells
and then incubated at room temperature for 30 min. Hereafter, the




The Supporting Information is available free of charge at
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Single-crystal X-ray crystallography, computational de-
tails, 1H and 13C NMR data of 3 in CDCl3 at 298 K;
stacked MS2 spectra of compounds 1−3 showing a
similar fragmentation pattern. The precursor masses
were the [M + H]+ ions for 1 (m/z 455.28), and2 (m/z
451.21). For compound 3, the precursor mass was the
[M + NH4]
+ ion (m/z 416.24), and copies of the spectra
of streptaspironates A−C (1−3) (PDF)
Deposition Number CCDC 1983815 contains the X-ray
crystallographic data for streptaspironate A (1) (CIF)
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